INTS

Intensity TherapeuticsF

Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences

At close

2026-06-03

View Chart

RSI (14)

18.2

Oversold

MACD Hist

-0.02

Bearish

ATR (14)

0.21

Normal

Vol Z (20)

0.56

Normal

RET 20D

-22.8%

Negative

Dist 52W High

-87.8%

Below High

Technical chart

1 Year

Candles, moving averages, and volume using the current RankAlpha theme.

As of 2026-06-03

Price

SMA 20

SMA 50

SMA 200

Trend readout

Technical readout

Trend

Downtrend (SMA20 < SMA50 < SMA200)

Momentum

Negative momentum · 20D -22.8% · 60D -47.9%

RSI / MACD

RSI 18.2 (Oversold) · MACD hist -0.02

Volatility

Volatility normal (Z 0.56)

SMA20

4.67

SMA50

5.15

SMA200

7.88

EMA12

4.47

EMA26

4.76

BB Upper

5.26

BB Mid

4.67

BB Lower

4.08

RET 5D

-9.0%

RET 20D

-22.8%

RET 60D

-47.9%

RET 120D

-70.8%

As of 2026-06-03 • Updated nightlySource: Internal modelMethodology